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Abstract
Paranodal myelin damage is observed in white matter injury. However the culprit for such damage remains unknown. By
coherent anti-Stokes Raman scattering imaging of myelin sheath in fresh tissues with sub-micron resolution, we observed
significant paranodal myelin splitting and retraction following glutamate application both ex vivo and in vivo. Multimodal
multiphoton imaging further showed that glutamate application broke axo-glial junctions and exposed juxtaparanodal K
+
channels, resulting in axonal conduction deficit that was demonstrated by compound action potential measurements. The
use of 4-aminopyridine, a broad-spectrum K
+ channel blocker, effectively recovered both the amplitude and width of
compound action potentials. Using CARS imaging as a quantitative readout of nodal length to diameter ratio, the same kind
of paranodal myelin retraction was observed with applications of Ca
2+ ionophore A23187. Moreover, exclusion of Ca
2+ from
the medium or application of calpain inhibitor abolished paranodal myelin retraction during glutamate exposure.
Examinations of glutamate receptor agonists and antagonists further showed that the paranodal myelin damage was
mediated by NMDA and kainate receptors. These results suggest that an increased level of glutamate in diseased white
matter could impair paranodal myelin through receptor-mediated Ca
2+ overloading and subsequent calpain activation.
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Introduction
White matter of the central nervous system (CNS) is enriched in
myelinated axons which are critical for reliable and efficient action
potential conduction. The action potential is generated at nodes of
Ranvier and propagates via saltatory conduction. Adjacent to the
nodes are paranodes where axolemma and the lateral borders of
myelin sheath are connected through the adhesion junctions. The
integrity of paranodal domains is vital to fast action potential
conduction along myelinated axons. Irreversible injury to white
matter [1] leads to severe functional loss of the CNS in
neurological disorders including stroke [2], multiple sclerosis
(MS) [3], and spinal cord trauma [4]. Early electron microscopy
studies showed submyelinic vacuoles and detachment of perinodal
oligodendrocyte-axon loops in anoxic injury of rat optic nerves
[5,6]. Howell et al. observed the disruption of adhesion junctions
within and adjacent to actively demyelinating white matter lesions
in MS tissues [7]. Nevertheless, the culprit responsible for such
paranodal myelin injury remains elusive to date.
Studies using various animal models have suggested glutamate
excitotoxicity as a common pathway in white matter injury [8,9].
Abnormally high glutamate levels were found in the cerebrospinal
fluid of MS [3] and spinal cord injury [10] patients. Oligoden-
drocytes are known to be vulnerable to glutamate excitotoxicity
through activation of glutamate receptors [11,12]. Studies of ex vivo
spinal dorsal column [13] and cerebral white matter [14] have
shown that glutamate excitotoxicity could lead to death of
oligodendrocytes and loss of axonal conduction. Nevertheless,
whether and how glutamate impairs paranodal myelin remains to
be investigated.
The current paper employs coherent anti-Stokes Raman
scattering (CARS) microscopy to investigate glutamate-induced
myelin damage in a spinal cord ex vivo and in vivo. CARS
microscopy uses two pulsed lasers to coherently drive a specific
molecular vibration by tuning the beating frequency, i.e., the
frequency difference between the two lasers, to a Raman band
[15]. It allows vibrational imaging at a speed that is 10
6 times
faster than spontaneous Raman microscopy. As a spiral mem-
brane containing about 70% lipid by weight [16], CNS myelin
produces a large CARS signal from the high-density CH2 groups.
With a lateral resolution of 0.28 mm and an axial resolution of
0.70 mm, our CARS microscope could visualize paranodal myelin
flanking a node of Ranvier [17]. Moreover, laser-scanning CARS
microscopy has allowed label-free monitoring of lysophosphati-
dylcholine-induced myelin degradation [18]. In this work, we
utilize the label-free and real-time imaging capability of CARS
microscopy to quantitatively measure the paranodal myelin
damage over a large number of axons. We show for the first
time that glutamate toxicity causes splitting and retraction of
paranodal myelin and consequent exposure of juxtaparanodal K
+
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result from glutamate receptor-mediated Ca
2+ influx and subse-
quent activation of calpain.
Materials and Methods
Preparation of ex vivo spinal cord white matter
All animals used in this study were handled in strict accordance
with NIH guidelines for the Care and Use of Laboratory Animals. The
experimental protocol was approved by the Purdue Animal Care
and Use Committee. Adult female guinea pigs of 350–500 g
bodyweight and ages between 4–8 weeks old were anesthetized
deeply with 80 mg/kg ketamine, 0.8 mg/kg acepromazine, and
12 mg/kg xylazine and perfused transcardially with cold Krebs’
solution (NaCl 124 mM, KCl 2 mM, KH2PO4 1.2 mM, MgSO4
1.3 mM, CaCl2 2 mM, dextrose 10 mM, NaHCO3 26 mM, and
sodium ascorbate 10 mM). The spinal cord was quickly removed
from the vertebral column and placed in cold Krebs’ solution
bubbled with 95% O2/5% CO2. The extracted spinal cord was
first split into two halves by mid-line sagittal division and then cut
radially to separate the ventral white matter as previously
described [19]. Spinal tissues were maintained in continuously
oxygenated Krebs’ solution for at least an hour at room
temperature before imaging or recording.
In vivo glutamate treatment
7 Long-Evans Rats were anesthetized deeply with a mixture of
80 mg/kg ketamine and 5 mg/kg xylazine. A 3 mm63m mw i n d o w
on the spinal cord was exposed at T9-T11 by aseptic laminectomy.
3 mL sterile saline was subcutaneously injected into the rat during
surgery. In the glutamate group (Glut) including 4 rats, 0.1 mL of
1 mMglutamatesolutionwasgentlydroppedontotheexposedspinal
cord. After 1 min, the glutamate solution was aspirated by gauge pad,
and then another 0.1 mL glutamate solution was dropped. This
process was repeated till the total volume of glutamate solution used
was 1 mL. The last drop of glutamate solution was kept on the
exposed spinal cord and the opened tissue and skin were stitched
together. 12 h after the surgery, the rat was euthanized through
transcardial perfusion with cold PBS (pH=7.4), followed by PBS
solution containing 4% paraformaldehyde. The spinal cord was
extracted and post-fixed in 4% paraformaldehyde solution for at least
24 h. The exposed part and the upper part (toward the cervical part)
were sectioned into 100 mm longitudinal sections by vibratome. 3 or
4 dorsal sections near the dorsal surface were imaged by CARS
microscopy, and ratios of nodal length to nodal diameter were
analyzed. 3 rats in the control group (Ctrl) were treated in the same
way using 1 mL sterile saline.
CARS and two-photon excited fluorescence (TPEF)
imaging
The CARS imaging system is shown in Supplementary Figure
S1.Thetwobeamsatfrequencyvp and vsweregeneratedfromtwo
tightly synchronized Ti:sapphire lasers (Mira 900/Sync-lock,
Coherent Inc.). Both lasers have a pulse duration of 2.5 ps. The
two beams were parallel-polarized and collinearly combined. A
Pockels’ cell was used to reduce the repetition rate from 78 MHz to
7.8 MHz. The overlapping beams were directed into a laser
scanning microscope (FV300/IX70, Olympus Inc.) and focused
into a sample through a 60X water immersion objective lens
(numerical aperture=1.2). The epi-detected CARS signal was
collected in the backward direction with the same objective lens.
The frequency difference between the pump and Stokes beams,
vp2vs, was tuned to the symmetric CH2 vibration at 2840 cm
21.
The same picosecond laser beams were also used for TPEF imaging
of calcium indicators. The epi-detected TPEF signal was spectrally
separated from the CARS signal by a dichroic splitter. Both CARS
and TPEF signals were detected with the same type of
photomultiplier tube (PMT, R3896, Hamamatsu, Japan). The
average pump and Stokes laser power at the sample were around
3.6 mw and 1.2 mw, respectively. No photodamage to myelin was
observed. For real-time CARS imaging, the isolated ventral white
matter strip about 1 cm in length was directly mounted on a glass-
bottom culture dish (#P35G-1.5-14-C, MatTek Co. Ashland, MA)
and kept in oxygen-bubbled Krebs’ solution. For Ca
2+ imaging, the
cords were first incubated in a Ca
2+-free Krebs’ solution (Ca
2+ was
replaced with Mg
2+) that contained 40 mM Oregon Green 488 AM
(BAPTA-2, Molecular Probes, Eugene, OR) for 2 h and then
washed with normal Krebs’ solution (containing 2 mM Ca
2+) prior
to imaging. Our CARS imaging system uses a water immersion
objective. Since accelerated water evaporation at 37uC would
therefore make long-time imaging difficult, all the imaging
experiments were carried out at room temperature (23uC).
Electrophysiological recording
Compound action potential (CAP) measurements in an ex vivo
spinal cord ventral column were carried out by using a double
sucrose gap chamber [19], as shown in Supplementary Figure S2. A
strip of spinal cord ventral white matter approximately 40 mm in
lengthwasplacedacrossthe chamberwith the centralcompartment
receiving a continuous perfusion of oxygenated Krebs’ solution
(2 mL/min). The temperature of the Krebs’ solution was
maintained at 37uC. The axons were stimulated at one end of the
strip and the CAP was recorded at the opposite end.
Treatments with pharmacological agents
L-glutamate sodium, kainic acid, 4-aminopyridine (4-AP), MK-
801, and GYKI52466 hydrochloride (Sigma, St. Louis, MO) were
directly dissolved in the Krebs’ solution. N-methyl-D-aspartate
(NMDA), NS-102, a-amino-3-hydroxy-5-methyl-4-isoxazolepro-
pionic acid (AMPA), and calcium ionophore A23187, MDL 28170
(Sigma) were first dissolved in DMSO and then diluted with
Krebs’ solution to a final desired concentration. The incubations
were carried out at room temperature except the examinations on
glutamate concentrations and glutamate receptor antagonists.
Immunohistochemistry
Antiserum against degenerated myelin basic protein (MBP)
(Millipore Corp. Billerica, MA) was used to examine the myelin
damage in the spinal cord white matter. This antibody stains myelin
only in damaged, but not intact, white matter regions [13,20].
Antiserum against Kv1.2antibody (Alomone Lab, Jerusalem,Israel)
was used to locate the K
+ channels at the juxtaparanodes. The
immunofluorescence images were taken by TPEF or confocal
fluorescence on the same laser-scanning microscope. A 543 nm He-
Ne laser was used for confocal fluorescence imaging.
Electron Microscopy
The ultrastructural change of myelin was characterized by
transmission electron microscopy (TEM). Both the glutamate-
treated and the control tissues were immersed into a fixative
solution (3% glutaraldehyde in 0.1 M cold cacodylate buffer
containing 2 mM MgCl2, 1 mM CaCl2, 0.25% NaCl, pH=7.4)
for 10 min. The tissues were then dissected into small pieces and
fixed for an additional 80 min. The dissected samples were rinsed
with 0.1 M cacodylate buffer three times and deionized water one
time, and then post-fixed in aqueous reduced osmium (1% OsO4
and 1.5% K3Fe(CN)6) for 90 min at room temperature. After
Glutamate Damages Myelin
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were dehydrated through a graded ethanol series, embedded in
Epon, and polymerized at 60uC for 48 h. Finally, the specimens
were dissected into thin sections (90–100 nm), stained with uranyl
acetate and lead citrate, and imaged on an FEI/Philips CM-10
bio-twin transmission electron microscope.
Statistical analysis
The statistical data were presented as mean6s.e.m. A paired
Student’s t-test was used to compare measurements between two
groups. ANOVA with Tukey’s test was used for multiple comparisons
within a group. For CAP measurements, n represents the number of
individual spinal white matter strips. For quantification of ratios of
nodal length to nodal diameter, n represents the number of nodes
analyzed for ratio calculations. The data in one group were obtained
from at least six spinal cord white matter strips which came from
three animals. For imaging of one spinal cord strip, we first randomly
chose one position as the starting point. Then, we acquired CARS
images of every node we found by moving the stage with raster-
scanning. We usually took 15–30 images of nodes per white matter
strip and at least 100 images of nodes per group.
Results
CARS imaging reveals paranodal myelin splitting and
retraction induced by glutamate
The response of paranodal myelin to glutamate application was
visualized on a laser-scanning CARS microscope. A typical myelin
structure around a node of Ranvier in an ex vivo spinal ventral
column is shown in Figure 1A. At 0 min, the paranodal myelin
loopsadjacent toanode wereclearlyresolvedbytheCARScontrast
from symmetric CH2 stretch vibration [17]. Myelin degradation
around the node following 1 mM glutamate application was
monitored in real time. At about 60 min, paranodal myelin was
observed to split originating from paranodal loops and extending
toward internodes. Along with splitting the paranodal myelin
retracted away from the node, leading to significant exposure of the
axon after 200 min. In the control sample without glutamate
treatment, neither myelin splitting nor retraction was observed
during 5 h incubation with oxygenated Krebs’ solution (Figure 1B).
To quantify the retraction of paranodal myelin from axons of
different diameters, we measured the ratio of nodal length to nodal
diameter at different time points of post-glutamate treatment. As
shown in Figure 1C, the nodal length is defined as the distance
between paranodal myelin at two ends along the node, which
includes the length of both node and additionally exposed axon
during paranodal myelin retraction. The nodal diameter is defined
as the distance between paranodal myelin at two sides across the
node. In the control sample without glutamate treatment, the
nodal length-to-diameter ratio was measured as 0.7660.03
(n=111). Incubation with 1 mM glutamate for 300 min increased
the ratio to 3.4560.29 (n=109). For the specific node shown in
Figure 1A, the application of glutamate increased the ratio by
more than 4 times in 220 min (Figure 1D).
The extent of white matter injury is highly sensitive to variation of
temperature [21,22]. Our real-time CARS imaging was performed at
room temperature of 23uC due to the use of water objective. To
compare the structural changes of paranodal myelin induced by
glutamate at physiological temperature of 37uC and at room
temperature of 23uC, we incubated the spinal tissues with 1.0 mM
glutamate for 2 h at 23uC, 5 h at 23uC, 1 h at 37uC, and 2 h at 37uC,
respectively. We observed the same structural changes, splitting and
retraction of paranodal myelin, at 37uC (Supplementary Figure S3),
but with an increased speed. At the same incubation time of 2 h, the
ratio of nodal length to diameter at 37uC is significantly higher than
that at 23uC (Figure 1E). The ratio obtained with 2-hour incubation
at 37uC is close to that obtained with 5-hour incubation at 23uC.
These results indicate that glutamate induces the same kind of
paranodal myelin damage at an accelerated rate under physiological
temperature, possibly due to more efficient enzymatic activities.
To explore the effect of glutamate on paranodal myelin under a
more physiological condition, in vivo glutamate treatment was
performed on the spinal cord of Long-Evans rats. In the extracted
spinal cord after in vivo treatment (Glut), paranodal myelin
retraction was extensively observed (Figure 1F). In the control
group with saline treatment (Ctrl), paranodes in the spinal cord
were tightly covered by myelin (Figure 1G). The measurements of
nodal lengths and nodal diameters (Supplementary Table S1)
showed that with similar nodal diameters the ‘Glut’ group at the
exposed site displayed larger nodal lengths (Figure 1H) than the
‘Ctrl’ group. And the ratio of nodal length to diameters was about
3 times larger than that of the ‘Ctrl’ group (Figure 1I). These
results demonstrate that glutamate could inflict paranodal myelin
retraction in the spinal cord of live animals.
Glutamate breaks axo-glial junctions and disrupts the
paranodal myelin
Normally the paranodal myelin is held on the axolemma by the
axo-glial junctions which segregate the Na
+ and K
+ channels along
the axolemma [23]. The observed splitting and retraction of
paranodal myelin by exposure to glutamate suggest the breakdown
of the axo-glial junctions. To examine whether this process did
occur, the spinal tissues were pre-incubated with Krebs’ solution
containing dextran-FITC (MW=4,400) as a fluid phase marker for
1 h prior to glutamate exposure. The myelin (red) change and the
dextran-FITC (green) distribution were simultaneously monitored
by CARS and TPEF, as shown in Figure 2A. The dextran-FITC
was initially kept in the extracellular space (0 min). With glutamate
application that resulted in the paranodal myelin splitting, the
dextran-FITC leaked into the split myelin (63 min) and eventually
into the injured axon (300 min). In the control experiment where
the spinal tissues were incubated with Krebs’ solution for 5 h, no
dextran-FITC accumulation was observed in the periaxonal space,
myelin or axon. Hence, the diffusion of dextran-FITC into the split
myelinclearlydemonstratesthat glutamatetreatmentresultedinthe
breakdown of axo-glial paranodal junctions. To determine whether
this process is associated with myelin degradation, we further
performed immunostaining of degraded MBP. In a glutamate-
treated sample (Glut, ratio of nodal length to diameter=3.5), the
paranodal region shows a weak CARS signal (red) by the action of
myelin splitting and retraction, whereas a relatively strong
fluorescence signal (green) from degraded MBP was observed
(Figure 2B). On the contrary, a control sample without glutamate
application (Normal, ratio of nodal length to diameter=1.3)
displayed a much weaker signal of degraded MBP (Figure 2C).
This result demonstrates that glutamate treatment resulted in
degradation of paranodal myelin.
The glutamate-induced breakdown of axo-glial junctions and
paranodal myelin disruption were also supported by EM images
(Figure 2D and 2E). In a glutamate-treated sample, we observed the
rupture of junctions, paranodal myelin disruption and retraction
(Figure 2E), which were characterized by the detachment of
paranodal myelin from axolemma, myelin debris and an elongated
node, respectively.
Exposure and redistribution of juxtaparanodal K
+ channels
Paranodal myelin retraction is expected to expose K
+ channels.
It is known that a high density of voltage-gated K
+ channels,
Glutamate Damages Myelin
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at the juxtaparanodes and protected by myelin [24,25]. The K
+
channel distribution was examined by imaging of immunostained
Kv1.2 channels (Figure 2F–2H). In normal samples (Figure 2F),
the Kv1.2 channel (green) was concealed beneath the compact
paranodal myelin (red). In glutamate-treated samples, disruption
of paranodal myelin (CARS, red) and subsequent exposure of
Kv1.2 channels (TPEF, green) (Figure 2G) were observed.
Furthermore, 30.3% exposed potassium channels displayed the
displacement of Kv1.2 channel to the paranodes and node
(Figure 2H). The redistribution of K
+ channel further demon-
strates the breakdown of the axo-glial paranodal junctions.
Figure 1. Real-time CARS imaging of paranodal myelin splitting and retraction induced by glutamate in spinal cord white matter. (A)
CARS images of paranodal myelin after different periods of 1 mM glutamate treatment ex vivo. (B) CARS images of paranodal myelin in the control
sample ex vivo without glutamate treatment. Little change was observed in paranodal myelin after 300 min. (C) Schematic nodal length and nodal
diameter.(D)Changes ofthenodal length-to-diameter ratio with time for thenodes in (A)and(B). (E) Temperature effect ontheratiosof nodallengthto
diameter. * p,0.001 compared with the ‘Ctrl’ group at the corresponding temperature. ** p,0.001 between two indicated groups. (F) Typical CARS
image of paranodal myelin in the rat spinal cord after 12 h of in vivo 1 mM glutamate treatment. (G) Typical CARS image of paranodal myelin in the rat
spinal cord after 12 h of in vivo saline treatment. (H) With similar nodal diameters, the in vivo glutamate-treated group (Glut) shows larger nodal length
than the in vivo saline-treated group (Ctrl). (I) The in vivo glutamate-treated group has 3 times larger ratios of nodal length to nodal diameter than the in
vivo saline-treated group. Each column represents the mean ratio of nodal length to nodal diameter measured from one rat. Bar=10 mm.
doi:10.1371/journal.pone.0006705.g001
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conduction
The juxtaparanodal K
+ channels normally contribute little to
axonal conduction, whereas their exposure following demyelin-
ation was shown to result in loss of axonal conduction [26].
Meanwhile, application of glutamate through the perfusion
medium has been shown to cause a striking decrease of CAP
amplitude in spinal dorsal columns [13]. To quantify glutamate
toxicity on impulse conduction, a double sucrose gap chamber
(Supplementary Figure S2) [19] was used to record CAP from a 4-
cm ventral column from guinea pig spinal cord. It was found that
the CAP amplitude declined to 65.069.2% of the initial value (Pre
in Figure 3A and 3B) after exposure to 1 mM glutamate for 2 h.
Washing with normal Krebs’ solution for 1 h did not stop the
decline in CAP amplitude, decreasing, instead, to 54.1612.5%.
Importantly, the CAP width, defined as the CAP trace width at
half amplitude, reduced from 0.3160.03 ms to 0.2360.02 ms
(Figure 3C and 3D) after 2 h of glutamate application. Washing
with normal Krebs’ solution for 1 h made no significant change in
CAP width. In control spinal ventral columns perfused with
normal oxygenated Krebs’ solution, the CAPs showed little change
during 4 h [27].
Glutamate-induced axonal conduction deficit can be
recovered by 4-AP
Application of 4-AP, a K
+ channel blocking agent, has been
shown to increase both CAP amplitude and width in focally
demyelinated axons [28]. 4-AP has also been found to restore
conduction of demyelinated pathways in acute and chronic spinal
cord injury models [29,30] and MS patients [31]. To examine its
effect on glutamate-treated samples, we added 100 mM 4-AP to
the perfusion solution following glutamate treatment. It was found
that incubation of glutamate-treated spinal ventral columns with
4-AP for 1 h restored the CAP amplitude to 157620% of the
value after glutamate treatment/washing and before 4-AP
application (Figure 3E and 3F). The 4-AP application also
Figure 2. Glutamate application breaks axo-glial junctions, disrupts paranodal myelin and subsequently exposes juxtaparanodal
K
+ channels. (A) Time-lapse images showing the leakage of dextran-FITC into the split myelin after glutamate application. The myelin (red) and
dextran-FITC (green) were monitored by CARS and TPEF, simultaneously. (B) and (C) CARS images of myelin sheath (red) and confocal fluorescence
images of degraded MBP (green) in spinal tissues after incubation in 1 mM glutamate solution (Glut) or normal Krebs’ solution (Normal). The curves
on the left of the images are intensity profiles of the lines indicated in the images. (D) EM images in a normal tissue show the paranodal myelin held
in tight contact with the axolemma. The right panel is the magnified image of the dash frame in the left panel. (E) EM images show that glutamate
induces paranodal myelin splitting (arrow), disruption and retraction. The right panel is the magnified image of the dash frame in the left panel. An
elongated node, detachment of paranodal myelin from axolemma (arrow head), and disrupted myelin debris (star) were observed. (F)–(H) CARS
images of myelin sheath (red) and TPEF images of Kv1.2 channels (green) at the juxtaparanodes after normal Krebs’ solution (F, Normal) and
application of glutamate (G–H, Glut). Both the exposure of Kv1.2 channels (G) and displacement of Kv1.2 channels into paranodes and node (H) were
observed. For (D) and (E), bar=1 mm. For (A)–(C) and (F)–(H), bar=10 mm.
doi:10.1371/journal.pone.0006705.g002
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(Figure 3G and 3H). After washing with normal Krebs’ solution
for 1 h, the CAP amplitude changed back to 10064.1% of that
before 4-AP application (Figure 3E) and the CAP width returned
to 0.2360.02 ms (Figure 3G). Application of 100 mM 4-AP to
ventral columns without glutamate treatment did not significantly
affect the CAP amplitude or width [30]. The reduction of CAP
amplitude and width together with the 4-AP data supports that
glutamate-induced functional loss is caused by the observed
retraction of paranodal myelin and consequent exposure of K
+
channels beneath the myelin.
Calcium influx and calpain activation are involved in
glutamate-induced paranodal myelin damage
Glutamate receptors have been shown to display Ca
2+
permeability [32], and Ca
2+ influx through these receptors
contributes to neuronal death in several pathophysiological
conditions, such as anoxia/ischemia and trauma [1]. To evaluate
the role of Ca
2+ influx in paranodal myelin damage, we incubated
the spinal ventral column in oxygenated Krebs’ solution
supplemented with 250 mg/mL Ca
2+ ionophore A23187. Similar
to the results obtained from glutamate application, CARS imaging
revealed paranodal myelin splitting and then retraction
(Figure 4A), with the ratio of nodal length to diameter increasing
by nearly 10 times in 250 min (Figure 4B).
The role of Ca
2+ in glutamate-induced paranodal myelin
damage was quantitatively studied by measuring the nodal length-
to-diameter ratio in four groups of tissues. The samples in each
group were incubated with normal Krebs’ solution (Ctrl), Ca
2+-
free Krebs’ solution (Ca
2+-free), Ca
2+-free Krebs’ solution plus
1 mM glutamate (Ca
2+-free + Glut), and normal Krebs’ solution
plus 1 mM glutamate (Glut), respectively. After 300 min incuba-
tion with different solutions, we measured the nodal length-to-
diameter ratios in the CARS images. It was found that the ‘Glut’
group displayed an average nodal length-to-diameter ratio 4.54
times larger than the ‘Ctrl’ group, whereas both the ‘Ca
2+-free’
and ‘Ca
2+-free + Glut’ groups displayed no significant difference in
ratios of nodal length to diameter compared with the ‘Ctrl’ group
(Figure 4C). In other words, by exclusion of Ca
2+ from the
incubating solution, paranodal myelin damage was avoided,
strongly suggesting that glutamate-induced paranodal myelin
change is a Ca
2+-dependent process.
We further examined the involvement of calpain in this process.
Calpains represent a family of Ca
2+-dependent proteinases which
break down myelin through degrading myelin basic proteins [33].
The ventral spinal column was pre-incubated for 60 min with
calpain inhibitor III MDL 28170, a broad cell-permeable calpain
inhibitor. Then glutamate was added into the incubating solution
to the final concentration of 1 mM. We found that MDL 28170
significantly reduced the glutamate-induced damage to paranodal
myelin and the ratio of nodal length to diameter for MDL 28170-
treated samples (‘Calpain inhibitor’ group in Figure 4C) decreased
almost 3 times compared with the ‘Glut’ group. This result clearly
shows that calpain plays an important role in the pathway of
glutamate excitotoxicity.
Glutamate excitotoxicity in paranodal myelin is mediated
by kainate and NMDA receptors
It has been shown that NMDA receptors are expressed in the
developing and mature CNS myelin and play a crucial role in
ischemic injury [34,35,36]. On the other hand, previous studies
have also shown that blockade of AMPA/kainate, but not NMDA
receptors, provided functional and histological protection against
ischemia [37,38]. To determine what subtypes of glutamate
receptors are involved in glutamate-induced paranodal myelin
damage, we carried out CARS imaging of spinal tissues after 5-
hour incubation with Krebs’ solutions containing the glutamate
receptor agonists NMDA, AMPA, and kainate, respectively. The
splitting and retraction of paranodal myelin, characterized by an
increase of the ratio of nodal length to diameter by more than 2
times, were observed in 25% of spinal tissues (n=16) treated with
0.68 mM NMDA and 40% of spinal tissues (n=15) treated with
Figure 3. Effect of glutamate (Glut) and 4-AP on CAPs in ex vivo
spinal ventral columns. (A) Histogram showing an irreversible
increase in mean peak CAP amplitudes (normalized to 100% of the
CAP amplitude (Pre) prior to glutamate treatment) after 1 mM
glutamate treatment. (B) Representative CAP recordings before and
after glutamate treatment and washing. (C) Histogram showing a
decrease in CAP widths at half amplitude after glutamate treatment. (D)
Representative CAP recordings showing a width decrease after
glutamate treatment. The CAP amplitudes were normalized to the
same level of pre-glutamate treatment (Pre) in order to compare CAP
widths at half amplitude. (E) Histogram showing an increase in mean
peak CAP amplitudes (normalized to 100% of the CAP amplitude (1 mM
Glut) after glutamate treatment and washing) after 100 mM 4-AP
treatment. (F) Representative CAP recordings before and after 4-AP
treatment. (G) Histogram showing an increase in CAP widths at half
amplitude after 4-AP treatment. (H) Representative CAP recordings
showing a width increase after 4-AP treatment. The CAP amplitudes
were normalized to the same level of that before 4-AP treatment (1 mM
Glut, after glutamate treatment and washing) in order to compare CAP
widths at half amplitude. In all cases, a paired Student’s t-test was used
to compare measurements between two groups (n=6).
doi:10.1371/journal.pone.0006705.g003
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0.16 mM AMPA. Typical imaging results are shown in Figure 5A,
5B and 5C, respectively.
We also measured the ratios of nodal length to diameter after 5-
hour treatment of spinal tissues at room temperature with NMDA,
AMPA and kainate, respectively. As shown in Figure 5D, the
nodal length-to-diameter ratios for the NMDA- and kainate-
treated groups were 1.4960.09 (n=187) and 1.7960.08 (n=192),
respectively, which showed significant difference (*p,0.001) in
comparison with the control group (0.7660.03) without any
agonist. On the other hand, the ratio of 0.9660.05 (n=177) for
the AMPA-treated group did not significantly differ from the
control group (p.0.05), consistent with the observation that no
paranodal myelin retraction happened with AMPA treatment
(Figure 5C). The role of NMDA and kainate receptors was
confirmed by applications of a noncompetitive NMDA receptor
antagonist MK-801, a selective AMPA receptor antagonist
GYKI52466, and a selective kainate receptor antagonist NS-
102, respectively. As shown in Figure 5E, co-application of MK-
801 (10 mM) or NS-102 (20 mM) with glutamate (1 mM) partially
protected the paranodal myelin from the glutamate excitotoxicity.
Correspondingly, the ratios of nodal length to diameter were
reduced by nearly 45%. In contrast, co-application of GYKI52466
(30 mM) with glutamate did not prevent the paranodal myelin
retraction. As a control, no paranodal myelin damage was
observed with applications of individual antagonists. In summary,
these results demonstrate that paranodal myelin damage induced
by glutamate is mainly mediated by NMDA and kainate receptors.
Paranodal myelin retraction precedes axonal injury
As a consequence of the severe retraction of paranodal myelin,
the axon cylinder is directly exposed to the ambient glutamate. To
examine axonal injury, we pre-incubated the spinal tissues with a
cell-permeable Ca
2+ indicator, Oregon Green 488 AM BAPTA-2,
in a Ca
2+-free Krebs’ solution for 2 h. After washing with normal
Krebs’ solution, we treated the spinal tissue with 1 mM glutamate
and monitored the paranodal myelin by CARS and Ca
2+ by TPEF
simultaneously. Before glutamate application (0 min), the TPEF
signal mainly arose from the fibrous structures between myelinated
axons (Figure 6A). These fibrous structures were shown to be
astrocyte processes in the white matter [39]. The intracellular Ca
2+
level in the axon was observed to start increasing at 240 min
(Figure 6B). In contrast, paranodal myelin had significantly
retracted at 160 min, and by 240 min had retracted to a nodal
length-to-diameter ratio of 2.4 (Figure 6B). In the control sample
without glutamate treatment, the axon cylinders did not show any
detectable signal of Oregon Green 488 AM (data not shown). These
results demonstrate that Ca
2+ influx into the axon occurred after
Figure 4. Ca
2+ influx and calpain activation are involved in glutamate-induced paranodal myelin damage. (A) Time-lapse CARS images
of paranodal myelin after different periods of treatment with 250 mg/mL Ca
2+ ionophore A23187. Bar=10 mm. (B) Increase of the nodal length-to-
diameter ratio with time for the node in (A). (C) Statistical analysis of ratios of nodal length to nodal diameter under five different conditions. ‘Ctrl’
represents samples incubated in Krebs’ solution. ‘Ca
2+-free’ represents samples incubated in Ca
2+-free Krebs’ solution. ‘Ca
2+-free + Glut’ represents
samples exposed to 1 mM glutamate in Ca
2+-free Krebs’ solution. ‘Glut’ represents samples exposed to 1 mM glutamate in normal Krebs’ solution.
‘Calpain inhibitor’ represents samples exposed to calpain inhibitor III MDL 28170 and glutamate together. Five groups of samples were exposed to
the different conditions for 5 h. * p,0.001 between the ‘Glut’ group and the ‘Ctrl’ group, and between the ‘Calpain inhibitor’ group and the ‘Glut’
group.
doi:10.1371/journal.pone.0006705.g004
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different positions (indicated by numbers in Figure 6A) was further
measured to explore the route of Ca
2+ influx into the axon. The
intensity levels after different time periods of glutamate application
are shown in Figure 6C. The elevation of Ca
2+ concentration was
faster at the exposed paranodes and juxtaparanodes (positions 2 and
3) than that at the internodes (positions 1 and 4). Therefore, it is
conceivable that Ca
2+ first entered the axons through the exposed
paranodes and juxtaparanodes and then spread to the internodes
along the axon cylinders.
Discussion
Growing evidence has shown that glutamate, a principal CNS
excitatory neurotransmitter, plays a key role in the pathology of
white matter diseases [9,40]. Elevated glutamate level was detected
in the normal-appearing white matter and acute contrast-
enhancing lesions of MS patients by magnetic resonance
spectroscopy [41]. Increased glutaminase (glutamate-producing
enzyme) expression in activated immune cells was found in active
MS lesions [3]. Furthermore, glutamate receptor antagonists were
found to reduce neurological deficits in experimental autoimmune
encephalomyelitis, an animal model of MS [42,43]. Elevated
extracellular glutamate level was shown to result in the death of
oligodendrocytes [11,12] and neurons [44,45] through excitotoxic
mechanisms [40]. However, the role of glutamate in demyelin-
ation is not fully understood. In this study, the application of
CARS microscopy, a vibrational imaging tool with 3D sub-micron
resolution, allowed direct visualization of paranodal myelin
damage following glutamate application in spinal cord ex vivo
Figure 5. Glutamate excitotoxicity in paranodal myelin is mediated by kainate and NMDA receptors. (A) CARS images of paranodal
myelin under NMDA (0.68 mM plus 27 mM glycine) treatment at different time periods. 27 mM glycine was used to maximize activation of NMDA
receptors. (B) CARS images of paranodal myelin under kainate (1 mM) treatment at different time periods. (C) CARS images of paranodal myelin
under AMPA (0.16 mM) treatment at different time periods. (D) NMDA, kainate, but not AMPA induced paranodal myelin retraction. Black bars
represent the average ratios of nodal length to diameter under various treatments. White bars with patterns represent the percentages of paranodal
myelin damage under various treatments. * p,0.001 compared with the control. (E) Glutamate-induced paranodal myelin retraction is partially
diminished by antagonists of NMDA, kainate, but not AMPA receptor. MK-801 (a noncompetitive NMDA antagonist), GYKI52466 (a selective AMPA
antagonist) or NS-102 (a selective kainate antagonist) were used. The spinal tissues were pre-incubated in the Krebs’ solution supplemented with a
specific glutamate receptor antagonist at 37uC for 0.5 h. Glutamate (1 mM) was then added into the incubating solution. After additional 1 h
incubation, the nodal lengths and nodal diameters in the spinal tissue were measured by CARS. * p,0.001 compared with the ‘Glut’ group.
Bar=10 mm in (A–C).
doi:10.1371/journal.pone.0006705.g005
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to glutamate exposure at the concentration of 1 mM or 0.1 mM
(Supplementary Figure S4). Paranodal myelin loops were observed
to split and retract towards the internode (Figure 1A). The damage
was associated with breakdown of axo-glial junctions (Figure 2A
and 2E), disruption of paranodal myelin (Figure 2B and 2E), and
exposure and redistribution of juxtaparanodal K
+ channels
(Figure 2G and 2H).
The observed exposure and redistribution of K
+ channels was
supported by CAP recording of conduction impairment induced
by glutamate. The exposure of K
+ channels located at the
juxtaparanodes leads to excessive conductance of K
+ channels so
that the axolemma is held close to the equilibrium potential of K
+.
This shunting of local circuit currents through the K
+ channels
could impair the generation of action potentials, leading to the
reduction of the CAP amplitude (Figure 3A). For the same reason,
exposure of the K
+ channels could cause the faster repolarization,
which resulted in the decrease of the CAP width (Figure 3C). The
exposure of K
+ channels under the juxtaparanodes was further
confirmed by the application of 4-AP, a K
+ channel blocker which
increased both the CAP amplitude and width (Figure 3E and 3G)
after glutamate-induced conduction deficit. Although the inter-
nodal myelin damage might also contribute to the impaired
conduction [13], our results suggest that the disruption of
paranodal myelin induced by glutamate is an important
mechanism for the functional loss in the white matter injury.
Notably, 4-AP is currently undergoing clinical trials in patients
with MS or chronic spinal cord injury [28]. Our observations
provide direct visual evidence to support 4-AP as a potential drug
for the treatment of demyelinating disorders.
The role of AMPA, kainate and NMDA receptors in white
matter injury has been extensively examined. Based on studies on
cultured oligodendrocytes, AMPA and kainate receptors are
located on oligodendrocytes and they mediate cell death [11,12].
Further studies using isolated white matter showed that blockade
of AMPA receptors, not NMDA receptors provided functional or
histological protection against ischemia in adult mouse brain slice
[14], ischemia in mouse optic nerve [37,46], and glutamate
application in dorsal spinal cord of adult rats [13]. The treatment
of AMPA/kainate antagonist NBQX was demonstrated to prevent
oligodendrocyte death and axonal damage in experimental allergic
encephalomyelitis [42]. In vivo treatment of NMDA receptor
antagonist MK-801 failed to protect myelinated axons after focal
cerebral ischemia [47]. Recent studies however revealed that
functional NMDA receptors are expressed on myelin sheath in the
white matter of the developing and adult CNS tissues including rat
cerebellum and corpus callosum [34], and the mouse and rat optic
nerve [35,36,37], suggesting that the presence of NMDA receptors
is a common feature of myelin sheath regardless of its maturation
stage [48]. Interestingly, NMDA receptors on myelin were
Figure 6. Paranodal myelin retraction precedes axonal injury. (A) Simultaneously acquired CARS image of myelin sheath (red) and TPEF
image of a calcium indicator, Oregon green 488 AM (green), including a node of Ranvier during glutamate treatment. The Ca
2+ influx observed at
240 min was preceded by paranodal myelin splitting and retraction, which began at 60 min of glutamate treatment. Bar=10 mm. (B) Ratios of nodal
length to diameter for the node in (A) and intra-axonal TPEF signals recorded at different time points. FCa
2+ represents the TPEF intensity from Ca
2+
indicator Oregon green 488 AM. F0 is the background intensity. (C) The TPEF signal of Oregon green 488 AM at different positions marked in (A,
0 min) varied after glutamate application for 0 min (black), 240 min (red), 325 min (green) and 460 min (blue), respectively. The signal elevation
trends at the four positions implicate that Ca
2+ conceivably flew into axons via the exposed paranodes and juxtaparanodes and then spread into the
internodal area.
doi:10.1371/journal.pone.0006705.g006
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2+ accumulation [36] and cause myelin loss
[35] during chemical ischemia. Because AMPA receptors are
mainly located on oligodendrocyte somata, blockade of NMDA
receptors, not AMPA receptors prevented the injury to myelin
sheath [35]. In vivo treatment of NMDA receptor antagonist CNS
1102 following temporary focal ischemia was demonstrated to
prevent myelin sheath loss in the cerebral white matter from
ischemic injury [49]. In the current work, we found that NMDA
and kainate, but not AMPA were able to partially induce
paranodal myelin damage in isolated ventral spinal cord white
matter from adult guinea pig. This observation suggests that in our
model the paranodal myelin damage induced by glutamate may
be mediated by NMDA and kainate receptors located on the
paranodal myelin [50].
Our study further revealed the important role of calpain in
glutamate-induced paranodal myelin damage. Calpain activation
has been demonstrated to cleave myelin proteins including myelin
basic protein and myelin-associated glycoprotein [51] and
contribute to myelin disruption in animal models for spinal cord
injury [52] and MS [53]. Glutamate excitotoxicity is known to
play a major role in white matter injury of these disease models.
However, whether myelin damage induced by the elevated
glutamate level attributes to the activation of calpain has not
been examined. Our result shows that calpain inhibitor can
effectively reduce the paranodal myelin retraction when spinal
tissue was exposed to high concentration of glutamate and thus
demonstrates that calpain activation is essential for the process of
glutamate-induced myelin damage.
Calpain activation degrades myelin proteins such as MBP and
subsequently disrupts the structural integrity of myelin sheath. In
the paranodal axo-glial junctions, the oligodendrocyte transmem-
brane protein Neurofascin Nf155 connects with a complex of
paranodin/contactin-associated protein (Caspr) and contactin at
the axolemma [54,55]. It is therefore possible that the calpain
activation might disrupt the transmembrane protein Nf155 and
subsequently break the adhesion junctions between axolemma and
paranodal myelin. In accordance with our result, elongated
paranodal expression and disruption of Neurofascin Nf155 were
observed in MS demyelinating lesions [7]. Similar structural
changes of paranodal myelin implicate the possible involvement of
glutamate-induced paranodal myelin disruption in the demyelin-
ation process of MS patients. Notably, because Ca
2+ influx into
axons was observed to follow the paranodal myelin retraction
(Figure 6A), our data have excluded the possibility of breaking
adhesion junctions from the axonal side. The intra-axonal integrity
after 180 min of glutamate exposure was previously observed by
immunostaining of spectrin breakdown products [13].
The current work shows great potentials of CARS microscopy
in the study of white matter injury. First, CARS microscopy allows
label-free and real-time imaging of myelin sheaths in both healthy
and diseased states. Its 3D sub-micron resolution enables
monitoring of the detailed myelin changes around nodes of
Ranvier. Second, other nonlinear optical imaging techniques can
be integrated into a CARS microscopic platform for studying
multiple components in the white matter. For example, TPEF can
be incorporated to study calcium activity with the aid of a calcium
indicator. Sum frequency generation can be used to visualize
astroglial filaments in astrocyte processes [39]. Third, the label-
free molecular imaging capability makes CARS microscopy
appealing for in vivo study of myelin by avoiding the inefficient
diffusion and nonspecific binding of fluorophore probes in the
tissue environment [56]. Together, these capabilities open up new
opportunities in understanding the molecular mechanisms and
cellular pathways in demyelinating diseases.
Supporting Information
Figure S1 CARS energy diagram and imaging setup. (A) Energy
diagram of CARS. In a CARS process, two laser fields at the
pump (vp) and Stokes (vs) frequencies interact with a medium to
generate a new field at the anti-Stokes frequency vas =
(vp2vs)+vp. The CARS signal can be significantly enhanced
when the beating frequency, (vp2vs), is in resonance with a
molecular vibration. The coherent property leads the CARS signal
to increase quadratically with respect to the number of vibrational
oscillators in the focal volume. (B) CARS imaging setup. The two
laser beams at frequencies vp and vs were generated from two
tightly synchronized Ti:sapphire lasers (Mira 900/Sync-lock,
Coherent Inc.). Both lasers have a pulse duration of 2.5 ps. The
two beams were parallel polarized and collinearly combined. A
Pockels’ cell was used to reduce the repetition rate from 78 MHz
to 7.8 MHz. The overlapped beams were directed into a laser
scanning microscope (FV300/IX70, Olympus Inc.) and focused
into a sample through a 60X water immersion objective lens
(NA=1.2). The CARS signal can be detected by forward- and epi-
photomultiplier tube (PMT).
Found at: doi:10.1371/journal.pone.0006705.s001 (0.20 MB
PDF)
Figure S2 A double sucrose gap chamber for CAP recording.
Briefly, a strip of spinal cord ventral white matter approximately
40 mm in length was placed across the chamber with the central
compartment receiving a continuous perfusion of oxygenated
Krebs’ solution (2 mL/min). The stimulating and recording
electrodes were not in direct contact with the spinal cord tissue.
The temperature of the Krebs’ solution was maintained at 37uC.
The free ends of the white matter strip were placed across the
sucrose gap channels to side compartments filled with isotonic
(120 mM) potassium chloride. The sucrose gap was perfused with
isotonic sucrose solution at a rate of 1 mL/min. The white matter
strip was sealed with a thin plastic sheet and vacuum grease on
either side of the sucrose gap channels to prevent the exchange of
solutions. The axons were stimulated at one end of the strip and
the CAP was recorded at the opposite end.
Found at: doi:10.1371/journal.pone.0006705.s002 (0.06 MB
PDF)
Figure S3 Temperature effect on glutamate-induced para-
nodal myelin retraction. (A) CARS image of a node of Ranvier
(indicated by arrow) when the spinal tissue was incubated in
Krebs’ solution at 37uC for 2 h. (B) CARS image showing the
retraction of paranodal myelin (indicated by arrow) when the
spinal tissue was incubated with 1 mM glutamate at 37uCf o r
1h .B a r=1 0mm.
Found at: doi:10.1371/journal.pone.0006705.s003 (0.16 MB
PDF)
Figure S4 Concentration effect on the ratios of nodal length to
diameter. After spinal tissues were incubated with 0.1 mM
glutamate at 37uC for 2 h, the retraction of paranodal myelin
was observed and the ratio of nodal length to diameter was
significantly increased in comparison with the ‘Ctrl’ group
(without glutamate treatment). However, compared with the ratio
of the 1.0 mM glutamate group, the use of a lower concentration
significantly reduced the damage. Moreover, when the incubation
time was extended from 2 h to 5 h, the ratio did not increase.
These results indicate that glutamate-induced paranodal myelin
damage is a concentration-dependent process. * Significant
difference at p,0.001 level compared with the ‘Ctrl’ group.
Found at: doi:10.1371/journal.pone.0006705.s004 (0.01 MB
PDF)
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spinal cord treated with glutamate in vivo.
Found at: doi:10.1371/journal.pone.0006705.s005 (0.03 MB
PDF)
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